Michael G. Jorgensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael G. Jorgensen has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Hessam Nowzari
Department of Periodontology and
3 shared publicationsJ. Slots
University of Southern California School of Dentistry, Los Angeles, California, USA
2 shared publicationsJohn L. Morrison
Department of Preventive Medicine, Division of Biostatistics, University of Southern California, Los Angeles, CA, USA
2 shared publicationsJørgen Slots
Los Angeles, USA
2 shared publicationsA Safarian
University of Southern California School of Dentistry (H.N., M.G.J., A.S., S.M.), Los Angeles, California, USA
1 shared publicationA. M. Pattison
University of Southern California, School of Dentistry, Los Angeles, CA, USA
1 shared publication
Latest Publications
- Open Access
Human Dento-Facial Evolution: Cranial Capacity, Facial Expression, Language, Oral Complications and Diseases
Objectives: To review dento-facial evolution based on fossil data, comparative anatomy, developmental biology and genetics. Modern human evolution reveals profound insight into the technical and biological challenges faced by clinicians in daily practice of dentistry. Materials and Methods: An analysis and review of the literature is presented to further explain the evolutionary forces that have shaped hominins. Results: Modern human evolutionary morphological and biological adaptations allowed improvement of cognitive ability, facial expression, smile and language. However, the increased cranial capacity correlates inversely with a decrease in size of the maxillary and mandibular bones, weakening of the muscles and facial shortening, contributing to dento-facial complications. Moreover, the distinctive differences in origin and development of the dento-facial components have further contributed to these maladies. In addition, human lifestyle transition from nomadic to sedentary increased the incidence of oral diseases. Conclusions: Knowledge of human evolutionary patterns can improve the quality of response by clinicians to biological challenges. The limitations in current treatment modalities can be explained, in part, due to the complexity of the life forms that resulted from evolution. Although there are no rules to predict how evolutionary forces will shape modern humans, the evolution of the dento-facial complex reveals profound insight into our connection to other forms of life and nature.
Open AccessHuman Dento-Facial Evolution: Cranial Capacity, Facial Expression, Language, Oral Complications and Diseases
Objectives: To review dento-facial evolution based on fossil data, comparative anatomy, developmental biology and genetics. Modern human evolution reveals profound insight into the technical and biological challenges faced by clinicians in daily practice of dentistry. Materials and Methods: An analysis and review of the literature is presented to further explain the evolutionary forces that have shaped hominins. Results: Modern human evolutionary morphological and biological adaptations allowed improvement of cognitive ability, facial expression, smile and language. However, the increased cranial capacity correlates inversely with a decrease in size of the maxillary and mandibular bones, weakening of the muscles and facial shortening, contributing to dento-facial complications. Moreover, the distinctive differences in origin and development of the dento-facial components have further contributed to these maladies. In addition, human lifestyle transition from nomadic to sedentary increased the incidence of oral diseases. Conclusions: Knowledge of human evolutionary patterns can improve the quality of response by clinicians to biological challenges. The limitations in current treatment modalities can be explained, in part, due to the complexity of the life forms that resulted from evolution. Although there are no rules to predict how evolutionary forces will shape modern humans, the evolution of the dento-facial complex reveals profound insight into our connection to other forms of life and nature.
- 1 August 2005
- Published by Elsevier in International Dental Journal
- Vol. 55 (1) , 3-12
Periodontal antimicrobials — finding the right solutions
- 1 August 2005
- Published by Elsevier in International Dental Journal
- Vol. 55 (1) , 3-12
Periodontal antimicrobials — finding the right solutions
- 10 August 2004
- Published by Wiley in Journal of Periodontal Research
- Vol. 39 (5) , 315-319
Initial antimicrobial effect of controlled‐release doxycycline in subgingival sites
Objectives: To determine the ability of a 10% doxycycline hyclate controlled‐release polymer (Atridox®) to suppress periodontopathic bacteria when placed subgingivally following scaling and root planing (Sc/Rp).Methods: Eight males and seven females, mean age 48 years, with moderate to advanced periodontitis participated in the study. In each patient, bilateral periodontal pockets probing 6–7 mm were randomly assigned to treatment by Sc/Rp + doxycycline polymer or by Sc/Rp alone. Subgingival placement of doxycycline polymer was carried out according to the manufacturer's instructions. Sc/Rp was performed with hand instruments for at least 10 min in each study tooth. Subgingival samples were collected by paper‐points at baseline, at 2 weeks and at 4 weeks post‐treatment. Culture methodology was used to isolate and identify putative periodontal pathogens, including Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Dialister pneumosintes, Tannerella forsythia, Prevotella intermedia/Prevotella nigrescens, Campylobacter species, Eubacterium species, Fusobacterium species, Peptostreptococcus micros, Eikenella corrodens, Staphylococcus species, enteric gram‐negative rods, β‐hemolytic streptococci and yeasts. The microbiologic examination was carried out blindly. Microbiological data were analyzed using a General Linear Model Analysis of Variance for within and between group effects.Results: Sites receiving Sc/Rp + doxycycline polymer and sites receiving Sc/Rp alone exhibited similar levels of periodontal pathogens at baseline and did not differ significantly in total viable counts and proportional recovery of periodontopathic bacteria post‐treatment.Conclusions: Controlled‐release doxycycline placed in moderate to deep periodontal pockets caused no significant additional reduction in the subgingival pathogenic microbiota compared to thorough Sc/Rp alone. Since controlled‐release doxycycline may not significantly suppress several subgingival pathogenic microorganisms and seems to possess no distinct advantage over broad‐spectra, safe and inexpensive antiseptics, the rationale for its employment in periodontal therapy remains unclear.
- 10 August 2004
- Published by Wiley in Journal of Periodontal Research
- Vol. 39 (5) , 315-319
Initial antimicrobial effect of controlled‐release doxycycline in subgingival sites
Objectives: To determine the ability of a 10% doxycycline hyclate controlled‐release polymer (Atridox®) to suppress periodontopathic bacteria when placed subgingivally following scaling and root planing (Sc/Rp).Methods: Eight males and seven females, mean age 48 years, with moderate to advanced periodontitis participated in the study. In each patient, bilateral periodontal pockets probing 6–7 mm were randomly assigned to treatment by Sc/Rp + doxycycline polymer or by Sc/Rp alone. Subgingival placement of doxycycline polymer was carried out according to the manufacturer's instructions. Sc/Rp was performed with hand instruments for at least 10 min in each study tooth. Subgingival samples were collected by paper‐points at baseline, at 2 weeks and at 4 weeks post‐treatment. Culture methodology was used to isolate and identify putative periodontal pathogens, including Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Dialister pneumosintes, Tannerella forsythia, Prevotella intermedia/Prevotella nigrescens, Campylobacter species, Eubacterium species, Fusobacterium species, Peptostreptococcus micros, Eikenella corrodens, Staphylococcus species, enteric gram‐negative rods, β‐hemolytic streptococci and yeasts. The microbiologic examination was carried out blindly. Microbiological data were analyzed using a General Linear Model Analysis of Variance for within and between group effects.Results: Sites receiving Sc/Rp + doxycycline polymer and sites receiving Sc/Rp alone exhibited similar levels of periodontal pathogens at baseline and did not differ significantly in total viable counts and proportional recovery of periodontopathic bacteria post‐treatment.Conclusions: Controlled‐release doxycycline placed in moderate to deep periodontal pockets caused no significant additional reduction in the subgingival pathogenic microbiota compared to thorough Sc/Rp alone. Since controlled‐release doxycycline may not significantly suppress several subgingival pathogenic microorganisms and seems to possess no distinct advantage over broad‐spectra, safe and inexpensive antiseptics, the rationale for its employment in periodontal therapy remains unclear.
- 18 December 2003
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (8) , 2949-2952
Human cytomegalovirus-associated periodontitis in renal transplant patients
- 18 December 2003
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (8) , 2949-2952
Human cytomegalovirus-associated periodontitis in renal transplant patients
- 30 April 2003
- Published by Wiley in Journal of Periodontal Research
- Vol. 38 (3) , 311-317
Povidone‐iodine as a periodontal pocket disinfectant
Objectives and background: Povidone‐iodine [polyvinylpyrrolidone‐iodine complex (PVP‐iodine)] might constitute a valuable adjunct to current periodontal therapy because of its broad‐spectrum antimicrobial activity, low potential for developing resistance and adverse reactions, wide availability, ease of use, and low financial cost. This investigation employed a randomized, split‐mouth study design to determine the microbiological and clinical effects of 10% PVP‐iodine subgingival irrigation in periodontitis lesions showing radiographic evidence of subgingival calculus.Methods: Sixteen adults having at least one periodontal pocket of 6 mm or more in each quadrant of the dentition and harboring one or more periodontopathic bacteria participated in the study. In each subject, a study site in each quadrant was randomly chosen to receive either subgingival irrigation with 10% PVP‐iodine together with scaling and root planing, scaling and root planing alone, subgingival irrigation with 10% PVP‐iodine, or subgingival irrigation with sterile saline. Prior to therapy and at 5 weeks post‐treatment, microbiological culture was carried out without knowledge of the clinical status or the type of treatment rendered. A blinded clinical examiner determined presence of dental plaque, probing pocket depth, and gingival bleeding on probing. Microbiological and clinical data were analyzed using a repeated measures analysis of variance and Kruskal–Wallis rank test with the Tukey and Mann–Whitney post hoc tests.Results: At 5 weeks post‐treatment, subgingival irrigation with PVP‐iodine together with scaling and root planing caused a 95% or greater reduction in total pathogen counts in 44% of pockets having ≥ 6 mm depth whereas scaling and root planing alone, povidone‐iodine irrigation alone and water irrigation alone caused 95% reduction of total pathogens only in 6–13% of similar study sites (P = 0.02). Reduction in mean pocket depth was 1.8 mm for the PVP‐iodine/scaling and root planing group, 1.6 mm for the scaling and root planing group, and 0.9 mm for the PVP‐iodine and the saline monotherapy groups, with statistical significance reached for the scaling and root planing group vs. the PVP‐iodine group (P = 0.04) and for the scaling and root planing group vs. the saline group (P = 0.02). Reduction in visible dental plaque, which ranged from 38% to 62%, showed no significant differences among treatment groups.Conclusions: The addition of subgingival PVP‐iodine irrigation to conventional mechanical therapy may be a cost‐effective means of reducing total counts of periodontal pathogens and helping control periodontal disease. However, subgingival irrigation with PVP‐iodine without concomitant mechanical debridement might not improve microbiological and clinical variables in comparison with saline irrigation, at least not in sites with radiographic evidence of subgingival calculus.
- 30 April 2003
- Published by Wiley in Journal of Periodontal Research
- Vol. 38 (3) , 311-317
Povidone‐iodine as a periodontal pocket disinfectant
Objectives and background: Povidone‐iodine [polyvinylpyrrolidone‐iodine complex (PVP‐iodine)] might constitute a valuable adjunct to current periodontal therapy because of its broad‐spectrum antimicrobial activity, low potential for developing resistance and adverse reactions, wide availability, ease of use, and low financial cost. This investigation employed a randomized, split‐mouth study design to determine the microbiological and clinical effects of 10% PVP‐iodine subgingival irrigation in periodontitis lesions showing radiographic evidence of subgingival calculus.Methods: Sixteen adults having at least one periodontal pocket of 6 mm or more in each quadrant of the dentition and harboring one or more periodontopathic bacteria participated in the study. In each subject, a study site in each quadrant was randomly chosen to receive either subgingival irrigation with 10% PVP‐iodine together with scaling and root planing, scaling and root planing alone, subgingival irrigation with 10% PVP‐iodine, or subgingival irrigation with sterile saline. Prior to therapy and at 5 weeks post‐treatment, microbiological culture was carried out without knowledge of the clinical status or the type of treatment rendered. A blinded clinical examiner determined presence of dental plaque, probing pocket depth, and gingival bleeding on probing. Microbiological and clinical data were analyzed using a repeated measures analysis of variance and Kruskal–Wallis rank test with the Tukey and Mann–Whitney post hoc tests.Results: At 5 weeks post‐treatment, subgingival irrigation with PVP‐iodine together with scaling and root planing caused a 95% or greater reduction in total pathogen counts in 44% of pockets having ≥ 6 mm depth whereas scaling and root planing alone, povidone‐iodine irrigation alone and water irrigation alone caused 95% reduction of total pathogens only in 6–13% of similar study sites (P = 0.02). Reduction in mean pocket depth was 1.8 mm for the PVP‐iodine/scaling and root planing group, 1.6 mm for the scaling and root planing group, and 0.9 mm for the PVP‐iodine and the saline monotherapy groups, with statistical significance reached for the scaling and root planing group vs. the PVP‐iodine group (P = 0.04) and for the scaling and root planing group vs. the saline group (P = 0.02). Reduction in visible dental plaque, which ranged from 38% to 62%, showed no significant differences among treatment groups.Conclusions: The addition of subgingival PVP‐iodine irrigation to conventional mechanical therapy may be a cost‐effective means of reducing total counts of periodontal pathogens and helping control periodontal disease. However, subgingival irrigation with PVP‐iodine without concomitant mechanical debridement might not improve microbiological and clinical variables in comparison with saline irrigation, at least not in sites with radiographic evidence of subgingival calculus.
- 13 September 2002
- Published by Wiley in Journal of Periodontal Research
- Vol. 37 (5) , 375-379
Initial effect of controlled release chlorhexidine on subgingival microorganisms
Background: Little or no data exist on the ability of subgingival application of PerioChip® (2.5 mg chlorhexidine gluconate in a biodegradable chip; Astra Pharmaceuticals, Westborough, MA, USA) to suppress periodontopathic microorganisms. The present study compared the subgingival microbiota of periodontitis sites receiving the chlorhexidine chip plus scaling and root planing (Sc/Rp) or Sc/Rp alone.Methods: Seven males and six females, mean age 49 years, with moderate to advanced periodontitis participated in the study. In each patient, two bilateral pockets probing 6–7 mm were randomly assigned to treatment by chlorhexidine chip + Sc/Rp, or by Sc/Rp alone. Subgingival placement of chlorhexidine chips was carried out according to the manufacturer's instructions. Sc/Rp was performed with hand instruments for at least 10 min in each study tooth. Subgingival samples were collected by paper‐points at baseline, at 2 weeks and at 4 weeks post‐treatment. Anaerobic culture methods were used for microbial isolation and identification. The microbiologic examination was carried out blindly. Microbiological data were evaluated by a repeated measures analysis of variance.Results: No statistical difference was found in total colony counts between subgingival sites treated with chlorhexidine chip + Sc/Rp and those treated with Sc/Rp alone. Also, the percentage of major periodontal pathogens (Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Bacteroides forsythus) and the percentage of total periodontal pathogens (A. actinomycetemcomitans, P. gingivalis, B. forsythus, Prevotella intermedia‐group, Fusobacterium, Eubacterium, Campylobacter rectus, Peptostreptococcus micros, Eikenella corrodens, enteric rods) were not significantly different between the chlorhexidine chip + Sc/Rp group and the Sc/Rp group. At baseline, A. actinomycetemcomitans was recovered from 4 chlorhexidine chip + Sc/Rp sites and 2 Sc/Rp sites, P. gingivalis from 5 chlorhexidine chip + Sc/Rp sites and 4 Sc/Rp sites, and B. forsythus from 9 chlorhexidine chip + Sc/Rp and 7 Sc/Rp sites. At 4 weeks, A. actinomycetemcomitans was detected in 2 chlorhexidine chip + Sc/Rp sites but not in any site receiving Sc/Rp, P. gingivalis in 2 chlorhexidine chip + Sc/Rp sites but not in any Sc/Rp site, and B. forsythus in 1 chlorhexidine chip + Sc/Rp and in 2 Sc/Rp sites.Conclusion: The present data obtained from bilateral periodontitis lesions of 13 adults suggest that chlorhexidine chip treatment of adult periodontitis lesions provides little or no additional antimicrobial benefits compared to thorough Sc/Rp alone.
- 13 September 2002
- Published by Wiley in Journal of Periodontal Research
- Vol. 37 (5) , 375-379
Initial effect of controlled release chlorhexidine on subgingival microorganisms
Background: Little or no data exist on the ability of subgingival application of PerioChip® (2.5 mg chlorhexidine gluconate in a biodegradable chip; Astra Pharmaceuticals, Westborough, MA, USA) to suppress periodontopathic microorganisms. The present study compared the subgingival microbiota of periodontitis sites receiving the chlorhexidine chip plus scaling and root planing (Sc/Rp) or Sc/Rp alone.Methods: Seven males and six females, mean age 49 years, with moderate to advanced periodontitis participated in the study. In each patient, two bilateral pockets probing 6–7 mm were randomly assigned to treatment by chlorhexidine chip + Sc/Rp, or by Sc/Rp alone. Subgingival placement of chlorhexidine chips was carried out according to the manufacturer's instructions. Sc/Rp was performed with hand instruments for at least 10 min in each study tooth. Subgingival samples were collected by paper‐points at baseline, at 2 weeks and at 4 weeks post‐treatment. Anaerobic culture methods were used for microbial isolation and identification. The microbiologic examination was carried out blindly. Microbiological data were evaluated by a repeated measures analysis of variance.Results: No statistical difference was found in total colony counts between subgingival sites treated with chlorhexidine chip + Sc/Rp and those treated with Sc/Rp alone. Also, the percentage of major periodontal pathogens (Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Bacteroides forsythus) and the percentage of total periodontal pathogens (A. actinomycetemcomitans, P. gingivalis, B. forsythus, Prevotella intermedia‐group, Fusobacterium, Eubacterium, Campylobacter rectus, Peptostreptococcus micros, Eikenella corrodens, enteric rods) were not significantly different between the chlorhexidine chip + Sc/Rp group and the Sc/Rp group. At baseline, A. actinomycetemcomitans was recovered from 4 chlorhexidine chip + Sc/Rp sites and 2 Sc/Rp sites, P. gingivalis from 5 chlorhexidine chip + Sc/Rp sites and 4 Sc/Rp sites, and B. forsythus from 9 chlorhexidine chip + Sc/Rp and 7 Sc/Rp sites. At 4 weeks, A. actinomycetemcomitans was detected in 2 chlorhexidine chip + Sc/Rp sites but not in any site receiving Sc/Rp, P. gingivalis in 2 chlorhexidine chip + Sc/Rp sites but not in any Sc/Rp site, and B. forsythus in 1 chlorhexidine chip + Sc/Rp and in 2 Sc/Rp sites.Conclusion: The present data obtained from bilateral periodontitis lesions of 13 adults suggest that chlorhexidine chip treatment of adult periodontitis lesions provides little or no additional antimicrobial benefits compared to thorough Sc/Rp alone.
- 1 August 2002
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 133 (8) , 1076-1082
Incidence of tooth sensitivity after home whitening treatment
- 1 August 2002
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 133 (8) , 1076-1082
Incidence of tooth sensitivity after home whitening treatment
- 1 November 2001
- Published by Wiley in Journal of Periodontology
- Vol. 72 (11) , 1601-1606
Aggressive Periodontitis Associated With Fanconi's Anemia. A Case Report
Background: Fanconi's anemia is an autosomal recessive disease associated with chromosomal breakage as well as pancytopenia, skin pigmentation, renal hypoplasia, cardiac defects, microcephaly, congenital malformations of the skeleton, hypogonadism, and increased risk of leukemia. The present report describes the periodontal clinical and microbiological status of an 11‐year old male having Fanconi's anemia.Methods: Polymerase chain reaction analysis to detect human cytomegalovirus (HCMV), Epstein‐Barr type 1 virus, and herpes simplex virus (HSV) was performed on paper‐point samples pooled from either 3 periodontal sites with advanced attachment loss or 3 gingivitis sites with no clinical attachment loss. Anaerobic bacterial culture examination was performed on the pooled periodontitis sample.Results: The patient suffered from pancytopenia, allergy, asthma, hearing impairment, and mental retardation. Dentition consisted of 7 primary teeth, 11 erupted permanent teeth, and 14 unerrupted permanent teeth. Most erupted teeth showed severe gingival inflammation with some gingival overgrowth and various degrees of periodontal attachment loss. Genomes of HCMV and HSV were detected in the pooled periodontitis sample and HCMV in the pooled gingivitis sample. The periodontitis sample but not the gingivitis sample revealed HCMV mRNA of major capsid protein, suggestive of active viral infection. The periodontitis sample also yielded Actinobacillus actinomycetemcomitans (1.1% of total isolates), Fusobacterium species (7.9%), Campylobacter species (2.2%), Peptostreptococcus micros (3.4%), and Candida albicans (0.3%).Conclusions: Oral features of Fanconi's anemia may include increased susceptibility to periodontitis. It is likely that underlying host defense impairment coupled with periodontal infection by HCMV and A. actinomycetemcomitans contribute to the severe type of periodontitis associated with Fanconi's anemia. J Periodontol 2001;72:1601‐1606.
- 1 November 2001
- Published by Wiley in Journal of Periodontology
- Vol. 72 (11) , 1601-1606
Aggressive Periodontitis Associated With Fanconi's Anemia. A Case Report
Background: Fanconi's anemia is an autosomal recessive disease associated with chromosomal breakage as well as pancytopenia, skin pigmentation, renal hypoplasia, cardiac defects, microcephaly, congenital malformations of the skeleton, hypogonadism, and increased risk of leukemia. The present report describes the periodontal clinical and microbiological status of an 11‐year old male having Fanconi's anemia.Methods: Polymerase chain reaction analysis to detect human cytomegalovirus (HCMV), Epstein‐Barr type 1 virus, and herpes simplex virus (HSV) was performed on paper‐point samples pooled from either 3 periodontal sites with advanced attachment loss or 3 gingivitis sites with no clinical attachment loss. Anaerobic bacterial culture examination was performed on the pooled periodontitis sample.Results: The patient suffered from pancytopenia, allergy, asthma, hearing impairment, and mental retardation. Dentition consisted of 7 primary teeth, 11 erupted permanent teeth, and 14 unerrupted permanent teeth. Most erupted teeth showed severe gingival inflammation with some gingival overgrowth and various degrees of periodontal attachment loss. Genomes of HCMV and HSV were detected in the pooled periodontitis sample and HCMV in the pooled gingivitis sample. The periodontitis sample but not the gingivitis sample revealed HCMV mRNA of major capsid protein, suggestive of active viral infection. The periodontitis sample also yielded Actinobacillus actinomycetemcomitans (1.1% of total isolates), Fusobacterium species (7.9%), Campylobacter species (2.2%), Peptostreptococcus micros (3.4%), and Candida albicans (0.3%).Conclusions: Oral features of Fanconi's anemia may include increased susceptibility to periodontitis. It is likely that underlying host defense impairment coupled with periodontal infection by HCMV and A. actinomycetemcomitans contribute to the severe type of periodontitis associated with Fanconi's anemia. J Periodontol 2001;72:1601‐1606.
- 1 September 1999
- Published by Wiley in Journal of Periodontology
- Vol. 70 (9) , 1008-1016
Tetracycline‐Coated Polytetrafluoroethylene Barrier Membranes in the Treatment of Intraosseous Periodontal Lesions
Periodontal pathogens are detrimental to periodontal healing in barrier membrane-assisted periodontal therapy. Tetracycline-coating of barrier membranes may reduce levels of infecting pathogens. This study evaluated the clinical and microbiological effects of tetracycline-coated expanded polytetrafluoroethylene (T-ePTFE) barrier membranes in the treatment of 2- to 3-wall intraosseous periodontal lesions around mandibular molars. Eleven patients received non-coated barrier membranes (ePTFE) and 11 patients received T-ePTFE barrier membranes. Tetracycline coating was performed by placing ePTFE membranes first in a 5% tridodecylmethylammonium chloride solution and then in a basic 3% tetracycline solution. Microbiological examination included conventional culture and DNA probe analyses. Barrier membranes were removed 6 weeks after insertion. At baseline, the periodontal lesion depth averaged 8.0 mm in the ePTFE treated group and 7.4 mm in the T-ePTFE group. At 1 year post-treatment, the mean gain of probing attachment was 1.9 mm in the ePTFE group and 3.3 mm in the T-ePTFE group (P = 0.02). At 3 minutes after membrane placement, suspected periodontal pathogens were detected in several ePTFE membranes but only in one T-ePTFE membrane. At 6 weeks, all membranes showed periodontal pathogens, including Porphyromonas gingivalis, Fusobacterium species, Peptostreptococcus micros, Bacteroides forsythus, and motile rods. This study suggests that the use of tetracycline-coated ePTFE barrier membranes can result in additional gain of clinical periodontal attachment, most likely due to the antimicrobial properties of tetracycline during initial healing.
- 1 September 1999
- Published by Wiley in Journal of Periodontology
- Vol. 70 (9) , 1008-1016
Tetracycline‐Coated Polytetrafluoroethylene Barrier Membranes in the Treatment of Intraosseous Periodontal Lesions
Periodontal pathogens are detrimental to periodontal healing in barrier membrane-assisted periodontal therapy. Tetracycline-coating of barrier membranes may reduce levels of infecting pathogens. This study evaluated the clinical and microbiological effects of tetracycline-coated expanded polytetrafluoroethylene (T-ePTFE) barrier membranes in the treatment of 2- to 3-wall intraosseous periodontal lesions around mandibular molars. Eleven patients received non-coated barrier membranes (ePTFE) and 11 patients received T-ePTFE barrier membranes. Tetracycline coating was performed by placing ePTFE membranes first in a 5% tridodecylmethylammonium chloride solution and then in a basic 3% tetracycline solution. Microbiological examination included conventional culture and DNA probe analyses. Barrier membranes were removed 6 weeks after insertion. At baseline, the periodontal lesion depth averaged 8.0 mm in the ePTFE treated group and 7.4 mm in the T-ePTFE group. At 1 year post-treatment, the mean gain of probing attachment was 1.9 mm in the ePTFE group and 3.3 mm in the T-ePTFE group (P = 0.02). At 3 minutes after membrane placement, suspected periodontal pathogens were detected in several ePTFE membranes but only in one T-ePTFE membrane. At 6 weeks, all membranes showed periodontal pathogens, including Porphyromonas gingivalis, Fusobacterium species, Peptostreptococcus micros, Bacteroides forsythus, and motile rods. This study suggests that the use of tetracycline-coated ePTFE barrier membranes can result in additional gain of clinical periodontal attachment, most likely due to the antimicrobial properties of tetracycline during initial healing.